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ABSTRACT 
Objectives 
Practitioners treating patients with haematological cancers have extensive clinical information 
available to give to patients, and patients need to be informed. However, many patients want to be 
protected from having information that is too detailed or threatening.  To illuminate how practitioners 
can address this dilemma and help patients feel appropriately informed, we explored patients’ 
experience of feeling informed or uninformed. 
Methods 
Semi-structured interviews were conducted with 20 patients who had been diagnosed with 
haematological cancer and had recently received results from clinical investigations or from 
evaluations of treatment response.   Inductive and interpretive analysis of the transcribed audio-
recorded interviews drew on constant comparison. 
Results  
Patients described the need for practitioners carefully to manage the information that they provided, 
and many felt alarmed by information that they did not experience as having been managed for them. 
A few patients who had difficulty trusting practitioners were not content with the information 
provided.  
Conclusions  
These findings can be understood using attachment theory, whereby practitioners’ careful 
management of information demonstrates their care for patients, and patients’ trust in the practitioner 
enables them to feel informed. It follows that, when patients do not feel informed, the solution will 
not necessarily be more information, but might be to help patients feel more secure in a caring clinical 
relationship.  
KEYWORDS 
Cancer; haematological oncology; information needs; attachment; clinical relationship; qualitative. 
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1 BACKGROUND 
Haematological cancers account for 7-9% of oncology cases in developed countries and a similar 
proportion of cancer-related deaths(1,2,3).  They are psychologically challenging(4) and patients face 
uncertainties throughout their illness. The course of disease is often unpredictable; conditions can 
evolve with time, and treatments need to be initiated or modified in response to changing clinical 
behaviour(5). Treatment options range from ‘watchful waiting’ to chemotherapy and stem cell 
transplantation, and can be unpleasant and hard to adhere to(1,2). Treatment decisions are dictated by 
complex clinical information from frequent assessments, including blood tests and imaging(1,2).  
While health policy has long recognized that patients should have information that allows them to be 
involved in treatment decisions(6,7,8), it can be unclear what this means in practice. Some guidance 
encourages cancer practitioners to provide ‘all available information’(9). This is often unrealistic, 
where more information is available than could be relayed in practice. Besides, there is evidence in 
cancer populations including haematological cancers that patients want protection from detailed or 
threatening information(10-14). Practitioners are therefore sometimes guided to give patients ‘the 
information they want’, but this also can be unrealistic where patients cannot know the extent and 
nature of available information(9).  
Haematological cancer patients’ own perspectives on receiving information from practitioners might 
inform more realistic guidance, but existing literature is contradictory. Reviews have concluded that 
patients were generally satisfied with information, despite often not knowing important details of their 
illness and treatment(15,16,17), and that they were more likely to feel informed if they trusted their 
practitioners(17). The aim of the present study was to explore patients’ experience of feeling informed 
or uninformed, in order to understand how practitioners can help them feel appropriately informed. 
Our aims were inductive; that is, we wanted to develop new ideas in a field in which existing ideas are 
limited. Therefore our approach was qualitative. 
2 METHOD 
4 
 
2.1 Sample and recruitment 
Purposive sampling included patients aged >18 years, diagnosed with haematological cancers and 
attending routine treatment and follow-up clinics in a specialist haematology service at a university 
teaching hospital from August 2014-April 2015. In their most recent (‘index’) consultation, patients 
received information from investigations or tests to inform diagnosis or treatment decisions or 
indicate treatment response. Index consultations were with consultants, specialist trainees in 
haematology, or a senior pharmacist in the haematology team (denoted generically as ‘practitioners’ 
henceforth). The practitioner that patients saw at any consultation depended on their needs at the time; 
patients therefore encountered several members of the team over time.  
After ethical approval (13/NW/0865), a practitioner introduced the research to suitable patients during 
the index consultation.  Maximum variation sampling entailed asking practitioners to select patients 
across a range of diagnoses, prognoses, treatment stage, gender and age seen in the clinic. Socio-
demographic details including highest educational qualification and type of occupation were recorded 
to confirm variability in these characteristics also.  Interested patients met the researcher (KA), who 
provided written information, reassured patients of her independence from the clinical team, 
explained that participation would not influence care and sought written consent. Patients were 
excluded if they were on palliative pathways or considered too distressed or unwell to consent. We 
recruited in parallel with analysis until judging that theoretical saturation was reached; i.e. new data 
did not modify the analysis. 
2.2 Data collection  
The researcher (trainee clinical psychologist with five years’ experience of research and clinical 
interviewing) interviewed consenting patients in a private room in the clinic or in patients’ homes, as 
each patient chose. Interviews were semi-structured and conversational, using open questions and 
reflection to facilitate talk, and closed questions to probe specific points. Using an interview guide, 
KA prompted patients specifically about: what information they received in the index consultation 
and on other key occasions and what it meant to them; and what significance the information had for 
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informing treatment or other decisions or for their lives more broadly. The guide was revised in line 
with ongoing analysis to explore emerging findings.  The researcher kept field-notes to record 
contextual information and reflexive observations. Interviews were audio-recorded, then transcribed, 
excluding identifying details.  Transcript extracts illustrate categories of the analysis below. Ellipses 
and square brackets indicate omitted and explanatory text, respectively. 
2.3 Data analysis 
Analysis drew on a pluralist qualitative approach, in which we sought ‘methodological integrity’ by 
adopting practices that ensured fidelity to the data and utility for the research question(18). Three 
authors (KA,BY,PS) read and discussed in detail the first five transcripts and associated field-notes to 
identify, as a starting point, features that were salient in the data and any that, given the context, were 
noticeably absent. Then KA led analysis in regular discussion with BY and PS, each of whom read all 
transcripts, and periodic discussion with NK who read selected transcripts. We used Microsoft Word 
to label and organize text using inductive headings that evolved over the analysis(19). Following a 
constant comparison approach(20), the developing analysis was tested and elaborated by reading and 
discussing additional transcripts as they became available. Differences of interpretation during 
discussions alerted the team to competing explanations, and identifying discrepant cases helped test 
and develop the analysis. The team included psychologists with research and clinical experience in 
psychological adjustment to cancer and in clinical communication, and a consultant haemato-
oncologist with research experience in lymphoid malignancies. Some authors had family experience 
of haematological cancers. We drew on these different perspectives as sources of alternative 
interpretations of data. We considered transcripts descriptively at first, with an interpretive approach 
then developing whereby we considered meaning of text in the context of each interview as a whole 
and the emerging analysis(21). We continually judged analysis according to consensus validity 
(through debate, it should satisfy all authors;22), reflexive validity (it should change authors’ initial 
and subsequent views;22), catalytic validity (it should have potential practice implications;22,23), and 
theoretical validity (it should have implications for theory;23). In presenting the final analysis, below, 
we describe salient recurrent or variant features of participants’ accounts, and our interpretation of 
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how these are linked(24). It is in the context of that ‘interpretive explanation’ that those features gain 
relevance to research question(25). 
3 FINDINGS 
3.1 Sample characteristics 
Four patients declined participation after seeing the researcher. Saturation was achieved with 20 
participants: 11 men and 9 women aged 26-85 years, with diverse educational and occupational 
backgrounds (Appendix 1). Time since diagnosis ranged from one week-13 years, treatment status 
from pre-treatment to post-treatment follow-up. Most index consultation were with a consultant; two 
and one, respectively, were with a specialist trainee or senior pharmacist. Five participants were 
interviewed at home; three had a partner present for all or part of their interview.  
3.2 Overview and interpretive explanation  
A striking feature of every patient’s account was the pervasive sense of uncertainty inherent in the 
illness, compounded by exposure to alarming information from non-clinical sources.  This was the 
context for understanding the main finding: that most patients valued practitioners managing 
information for them, allowing patients to feel ‘in the picture’ without challenging their need for 
protection from overwhelming threat. A few patients recounted previous experience that made it hard 
to trust practitioners’ care, and these patients were not content with practitioners’ management of 
information.  
3.3 The context of patients’ needs: the threat of an uncertain condition  
Patients were aware of the seriousness of their condition. Most referred explicitly to the possibility of 
dying, and described the intense uncertainty of a changeable condition. They lacked a predictable 
trajectory of treatment and recovery because therapeutic options depended on evolving clinical 
features. They described their disease as “a ticking time bomb”(P1) so that, even though “I thought 
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I’d beat it…it changed and went more aggressive.”  A few explained that even their practitioners 
could not “put their finger on”(P10) what was wrong. 
Patients were often alarmed by extraneous events that, although not explicitly related to their disease 
status, they interpreted threateningly, including unexpected telephone calls or letters inviting them to 
hospital, deaths of patients they befriended, or reports of public figures dying from haematological 
conditions. Non-clinical information sources were also apt to alarm. In particular, the Internet “will 
frighten the life out of you”(P9). Friends or family sometimes provided information, but only P12 
described this positively because “[sister] knows all about this, so she lets me have little dribs and 
drabs”. Others were alarmed by information from friends or family, as P15 illustrated: “[Father] is 
trying to make me more nervous…He’ll say ‘Do you understand the situation’ and ‘How you can 
really be so calm?’”. Patients therefore generally avoided information from non-clinical sources, 
relying on what they were given by practitioners.  For instance, P7 had received information from her 
son, who obtained it from colleagues in the drug company for which he worked, but she described 
feeling unable to make use of it, explaining: “there’s nothing we could do, we just accepted whatever 
[haematologist] said.” 
3.4 Patients needed practitioners to ‘manage’ information for them 
Patients were, in general, confident that practitioners knew what information to give and realistic 
about lacking the expertise to understand all the information available. For example, P6 explained that 
“they don’t tell you everything…he’s a doctor, he knows. If he thinks I should know he’ll tell me…I 
just accept it”.  This did not mean that practitioners generally denied information that patients wanted, 
as P15 explained: “I haven’t really asked them [about his subtype of Hodgkin’s Lymphoma] but all 
the questions I have asked they have told me.” From patients’ perspective, practitioners’ management 
of information had the three following elements. 
3.4.1 Constraining information protected patients 
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In general, patients described feeling protected, and comforted, by practitioners constraining clinical 
information.  P12 recounted being told of a “T-cell that’s broken off”. When asked if she wanted to 
know more, she replied “No I’ll leave it and let [doctors] deal with it… just at the moment I don’t 
want to take in any more”. Constraining information meant pacing, or “drip-feeding”(P20) it, but also 
avoiding detailed clinical information, particularly if it was threatening: “No-one wants to have it sort 
of possibly spelled out that ‘No we can’t do anything more for you now’”(P17). Several were 
explicitly asymmetric in their desire for information according to whether it was ‘good’ or ‘bad’, as 
P9 explained: “You only want to know good news.  I want to know how I’m going on if it’s good but if 
I’m not doing very well, better not knowing”. Similarly, when prompted about asking questions of the 
clinical team, P7 replied: “If the answer’s a bad one you don’t really want to know…bad news would 
just knock me down”.  
Patients actively collaborated in seeking protection from undesired information.  They chose not to 
ask certain questions. For instance, after being told his cancer was “higher grade”, P16 “never asked 
[what this signified].  I’m sure if I would have asked they would have told me.” P20 illustrated how 
protecting himself from knowing the possible duration of treatment relied on being able to disregard 
information. When asked whether there was any information that he wanted but had not obtained, he 
replied “No…although I’m sure I’ve been told but chose not to take it in, the worst case scenario of 
how long I’d be on the treatment…If I was told I was going to be on it for years initially it may have 
been a bit daunting...I probably was given the proper story but…chose not to recall it.”  Similarly, 
P15 “can sort of filter things out what’s important to me, what I want to take in I’ll just take that in”. 
A few patients did refer to wanting specific clinical information they had not received but, elsewhere 
in their interviews, were ambivalent about it or indicated that they did not want it or could have 
obtained it had they wished (Figure 1).  Three patients clearly wanted information that they had not 
been given (see ‘variant cases’ below). By contrast, several had received more information than they 
wanted, particularly during consent procedures when risk information associated with treatment felt 
“overwhelming” (P3).   
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 3.4.2 Focusing on a tangible marker helped patients feel ‘in the picture’ 
Patients valued practitioners providing visual markers of their condition. A few had seen scan images.  
For instance, P17 appreciated that  “[haematologist] did actually show me…the PET scan and he was 
able to point out…hot spots…In all the time I’ve had this cancer…I’ve never actually felt ill with 
it…It’s quite good to see in a way the visual image of ‘Oh gosh, there are things there.’”  Mostly, 
however, patients described blood markers. For instance, P20 recalled that his haematologist “did turn 
his computer around and he was showing me a chart, a graph of all the results”, even though “I can't 
remember which ones he showed me…Actually seeing a physical representation of the line actually 
dipping initially and then coming up…that worked for me.” Even when markers indicated 
deterioration, patients benefited. P9 recounted how his doctor “showed me the graph. Since that 
treatment it’s starting to creep all the way back up and it’s got to the level where it needs looked at”, 
explaining that it “puts me completely in the picture”. This kind of visual image helped patients in 
several ways (Figure 2). 
3.4.3 Showing efforts to manage information demonstrated practitioners’ caring  
Most patients felt that practitioners had prepared for their consultation, deciding beforehand what 
information to give. Using one patient’s account, Figure 3 illustrates the kinds of preparation that 
patients valued. Crucially, patients valued the preparation itself, regardless of specific information that 
ensued. That is, preparation indicated that practitioners cared. As P8 illustrated, his doctor made him 
feel “top of the agenda”, simply by telling him “they have a meeting about me every week”(P8).   
The importance of preparation was salient for the few patients who sensed its absence.  P19 spoke of 
being given a CT scan report which felt threatening because it indicated how advanced his condition 
was.  He complained that “without giving me that [report] they should have explained where it 
[disease] was”. When her consultant was away, P17 recalled a doctor who “had obviously not looked 
at my notes and it was very, very unsatisfactory…I came away feeling…‘Oh no, that was not good’, 
because she didn’t know the full story…Perhaps something might not get back to the doctor when he 
returned”. P3 felt lack of care after a junior doctor delivered results: “It would’ve been good to see the 
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main person for such an important set of results, felt important to us anyway, perhaps it wasn’t so 
important for them”.  
3.5 Patients managed information for others 
Just as they described practitioners managing information for them, patients in turn managed 
information for family to avoid ‘worrying’ them, creating ‘take-home’ messages such as “’The 
treatment…is working and things are diminishing’, that sort of thing and they…always say…’That’s 
great to hear’.”(P17) or even providing incorrect information: “I just told them like it was in two 
areas and actually it was in three or four…I just didn’t want to worry them”(P15). A few, such as P6, 
managed information for friends: “I’ll just say ‘Oh its clearing up’, but thing is, you’re going to say 
that anyhow even if it wasn’t, you’re going to put a ‘Oh they reckon it’s doing well’ on…When you’ve 
got cancer like, the word frightens people”(P6).   
3.6 Variant cases: patients with unmet information needs 
Most patients’ trust in practitioners to tell them what they needed to know was resilient to isolated 
challenges, such as finding a doctor unprepared. However, three patients described persistent, unmet 
information needs (Appendix 2). One had a strong sense of her own specialist knowledge and was not 
content with practitioners managing information for her.  Two others recounted apparent failures and 
delays in diagnosis and management that had challenged their ability to trust practitioners.   
4 DISCUSSION 
4.1 Main findings 
To our knowledge, this is the first study to identify the importance haematological cancer patients 
placed on practitioners ‘managing information for’, rather than ‘giving information to’, them. Despite 
intense uncertainty associated with their illness, patients did not, in general, want extensive clinical or 
prognostic information. Instead, trusting caring practitioners to select and manage information 
allowed patients to feel informed. Most trusted their practitioners and felt informed. The few who 
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wanted more information than they received did not fully trust practitioners to manage information for 
them.   
4.2 Findings in relation to literature 
The findings are consistent with quantitative evidence that patients with haematological cancers 
generally feel informed, despite variable knowledge of their condition(15,16,17). They are also 
consistent with previous qualitative findings that point to the clinical relationship as the key to how 
such patients can feel informed in a context in which information can be complex and threatening(17). 
However, our findings go beyond confirming the clinical relationship as the necessary context for 
feeling informed, to indicate the active role that both parties take in managing information.  
Given the intense threat and sense of vulnerability associated with the uncertainty inherent in their 
condition, patients were apt to interpret extraneous events or information from sources other than 
practitioners as alarming.  To protect themselves, they sought information preferentially from 
practitioners, selecting what they wanted to hear either by choosing what to ask or by selective 
hearing and remembering of what practitioners told them. Patients were not, in these ways, ‘denying’ 
their condition. Aware of its seriousness, they chose to avoid information that they knew or feared 
would be threatening, a psychological process that Salander termed ‘disavowal’(26). Patients also 
selected information for family and friends. While their stated motivation was to protect others(27), 
they thereby also protected their own disavowal from being challenged by others’ enquiries or 
sympathy.  
Patients also needed practitioners to manage information for them. Previous reports have shown that 
patients want practitioners to limit information, including in haematological cancers(10). However, 
our findings show the importance of practitioners managing information, not just limiting it. This 
meant, for example, showing graphs and other tangible markers that helped patients feel ‘in the 
picture’.  Crucially, patients wanted practitioners to give information asymmetrically; that is, to give 
information freely where it was ‘good’, but sparingly where it was ‘bad’, as reported previously in 
breast cancer(11) and in parents of children with leukaemia(28). Our findings build on Perakyla’s 
12 
 
account of practitioners’ role in ‘hope work’ in the context of life-threatening illness(29). Patients 
gave them this role, and could then collaborate with practitioners in constructing a picture of the 
future which sustained their hope(30). 
Research and policy literature on patients’ information needs in cancer typically refers to information 
as a ‘quantity’; i.e. it focuses on ‘how much’ information patients want about different topics. Our 
participants’ accounts indicated the limitations of this unidimensional view which disregards the 
different ways in which information can be conveyed.  Patients valued practitioners’ use of visual 
representations to simplify information, many appreciating being shown graphs on practitioners’ 
computers that made sense of treatment decisions, even if they did not remember the markers plotted. 
Being given this information helped patients accept what they were told about treatment(31). 
Appreciation of practitioners managing information went beyond the informational value of what 
patients were told or shown. Patients felt comforted by knowing that practitioners had thought about 
what information to provide. That is, patients inferred practitioners’ caring from how considerately 
they managed information, just as they might infer caring from how sensitively practitioners 
conducted a physical procedure.  
The responsibility that patients give practitioners for constraining and managing information 
resembles that in patients with solid tumours(11, 30, 32, 33), but is inconsistent with influential views 
of patients as ‘partners’ in care, to be ‘empowered’ by information. Indeed, only one ‘variant’ patient 
took this stance, and she was unusual in the sense of medical authority she felt. The responsibility is, 
though, consistent with suggestions that clinical relationships in cancer resemble attachment 
relationships(34, 35, 36, 37).  That is, patients attribute to practitioners the expertise and authority to 
look after them and to know what they need – including what information they need. This perspective 
helps explain why patients relied primarily on practitioners for information, disregarding the Internet 
or family members; they felt that only practitioners could take responsibility for managing 
information for them. 
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Our findings are also inconsistent with the separation in clinical communication research between 
affective and cognitive components of clinical communication(38).  Patients’ experience of being 
informed was interconnected with their sense of relationship. Patients felt informed, not necessarily 
because of information they received, but because they knew that practitioners whom they trusted 
were managing all their care, including information. Conversely, feeling that practitioners were 
managing information was itself evidence that they cared.  
4.3 Study limitations 
The inductive design allowed us to explore what mattered to patients and thereby to challenge 
influential assumptions around information needs. As a qualitative study, however, the results cannot 
automatically be generalized; patients were recruited from one clinic and findings might differ in 
others. The sample was clinically diverse because we sought findings relevant across the range of 
disease subtypes and treatment trajectories in haematological cancers; we might not have identified 
processes relevant to specific patient groups.  Nevertheless, the theoretical validity arising from 
convergence with previous studies in haematological cancers and other tumour groups suggests that 
our findings potentially have broad transferability. 
4.4 Clinical implications 
Although clinical communication policy typically assumes that patients need information to inform 
decisions(7), we saw this in only one, ‘variant’, patient with an unusual sense of her own medical 
authority. Instead, the main implications of our findings arise from the interconnectedness of 
information and clinical relationship.  
Research typically concludes that ‘unmet information needs’ in haematological cancer patients should 
be addressed by giving more information(17). However, our participants had mostly learned to avoid 
sources that provided information freely (i.e. those outside the clinical relationship), finding that more 
information was not the key to feeling informed; indeed, unmanaged information could make them 
feel less informed. Kalanithi likened this paradox to trying to quench thirst with salt water(39). 
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Instead, as Kalanithi also illustrated, patients relied on practitioners to judge what information they 
needed and manage information for them, not just respond to their requests(39). Most patients in our 
sample readily trusted practitioners and therefore felt informed. Where unmet information needs arise, 
they might indicate problems to be addressed in the clinical relationship(17). For instance, two 
patients felt overlooked during their care, lacked full trust in the care team, and expressed unmet 
needs for more, or more consistent, information.  
While practitioners need to respond to specific questions that such patients have, they also need to 
address the difficulties in trust that form the background to those questions. Although distribution of 
care across a multidisciplinary team might militate against the kind of attachment relationship that can 
help patients trust practitioners to manage information, a clinical team and its efficient operation 
might have properties of an attachment figure so that patients can feel comforted by being admitted 
into a ‘caring plan’(40). Nevertheless, the uncertainty and unpredictability in haematology makes 
such a ‘plan’ elusive for some patients, particularly those who have difficulties trusting practitioners. 
Therefore one way to facilitate patients’ trust might be to ensure that they know that a single 
practitioner, whom they see periodically or at turning points in treatment, oversees their care, i.e. that 
they have a ‘secure base’. This person could prepare the patient explicitly for potential difficulties 
around trusting practitioners when the course of treatment and illness is so unpredictable. Practitioners 
could also explain to patients their experience of working with uncertainty and that, where 
unpredicted events arise, there is a plan to manage these.  
4.5 Conclusion 
The overriding message is that patients did not want to take responsibility for judging what 
information they need. In the context of a trusting relationship, patients relied on practitioners for this 
role, as for other aspects of care. Practitioners will therefore inevitably sometimes give more or less 
information than patients want, and will need to be alert to needs they had not identified. However, 
while practitioners need to provide patients with the information they seek, they also need to 
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recognize that seeking more information can indicate patients’ difficulty in forming a trusting clinical 
relationship.  
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Figure 1. Five patients, including those illustrated here, said that they wanted specific information, but 
elsewhere in the interview indicated ambivalence. 
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Function of the information Illustrative text 
 
Enhanced trust in the doctor. “[Doctor] is absolutely 
wonderful, big charts [on 
doctor’s computer screen] every 
time and he explains everything. 
Very reassuring, he’s very, very 
good.” 
 
Explained clinical decisions. 
 
“I went for a few months and 
then I think my blood went up 
and up and up.  Showing me 
this chart, and he said ‘I think 
we’re going to have to start the 
chemo’, and he took me straight 
away to the chemo.” 
 
Anchored understanding of the 
illness. 
 
“The protein level, this is what 
started the whole thing in the 
first place.  It got so high that 
blood was going so slow around 
my body…Protein levels have 
gone up to a level where they 
need to be treated again.” 
 
Managed emotion in 
consultation. 
 
“Something to look at [in 
consultation]…obviously you’re 
a bit emotional and if you can 
look at something…as opposed 
to looking at somebody, if it’s 
bad news…that kind of helps.” 
 
Figure 2. Referring to being shown a chart on her doctor’s computer that tracked a specific protein 
indicator, P7 illustrated the range of reasons why patients valued such visual ‘markers’. 
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Figure 3. P1 illustrated the range of ways in which patients recounted their practitioners preparing for 
consultation. 
 
Form of preparation Illustrative text 
 
Selected information. “I suppose you have to make 
judgement calls don’t you, on 
how you tell people, what you 
tell people, in the time that 
you’ve got”. 
  
Took account of patient’s ability 
to manage or understand 
information. 
“They’d discussed and 
wondered how much to tell me 
but because I’d asked, I was 
knowledgeable and asked 
questions, I knew that they’d 
given me the full information”. 
 
Arranged take-home material. “He gave me loads of paper, 
booklets and different websites 
so I’ve got all the information 
to hand”. 
 
Met with other professionals to 
discuss patient’s needs and adjust 
care accordingly. 
 
“[Counsellor] had already been 
in and said ‘[patient] is waiting 
and she’s nervous’”.  
 
Knew the results to be delivered 
in advance. 
“As soon as I got in he just 
blurted out ‘It’s good news’, so 
yeah, which was relaxed, just 
relaxed me straight away.” 
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Appendix 1. Sample characteristics 
Partici-
pant  
number 
Gender Age-
band 
(years) 
Highest 
level of 
education 
Most recent 
job type 
Present 
work status 
Diagnosis Time 
since 
diagnosis  
Clinical 
situation 
Results 
given at 
index 
consult-
ation1 
Significance of 
results 
Time post-index 
consultation 
when 
interviewed 
(days) 
Place of 
interview 
1 Female 30-35 Higher 
education 
Professional/
Management 
Sickness 
absence 
Non- 
Hodgkin’s 
lymphoma 
6months Mid-course of 
treatment 
CT scan3 Treatment 
effective: continue  
 
7 Hospital 
2 Female 55-60 Higher 
education 
Care Sickness 
absence 
Non- 
Hodgkin’s 
lymphoma 
2weeks Newly 
diagnosed 
Blood 
tests 
More detailed 
diagnosis and 
treatment 
implications 
 
2 Home 
3 Male 65-70 Higher 
education 
Professional/
Management 
Retired Non- 
Hodgkin’s 
lymphoma 
8months Post-treatment CT scan2 Treatment 
effective 
 
2 Home 
4 Male 50-55 School Manual Working Chronic 
lymphocytic  
leukaemia 
10years Recently began 
treatment 
Blood 
tests 
Treatment 
effective: continue 
 
14 Home 
5 Female 80-85 School Manual Retired Chronic 
lymphocytic  
leukaemia 
13years Mid-course of 
treatment 
Blood 
tests 
Treatment 
effective: continue 
 
14 Home 
6 Male 70-75 School Manual Retired Hodgkin’s 
lymphoma 
5months Mid-course of 
treatment 
PET scan Treatment 
effective: continue 
 
14 Hospital 
7 Female 65-70 Higher 
education 
Professional/
Management 
Retired Chronic 
lymphocytic 
leukaemia 
2-3years Mid-course of 
treatment 
Blood 
tests 
Treatment 
effective: continue 
 
 
28 Hospital 
8 Male 50-55 School Manual Sickness 
absence 
Non-
Hodgkin’s 
lymphoma 
6years Mid-course of 
treatment  
CT scan 
and blood 
tests 
Treatment 
effective: continue 
 
 
28 Hospital 
9 Male 65-70 School Manual Retired Non- 
Hodgkin’s 
lymphoma 
 
5years Watchful 
waiting 
Blood tests Indicate need to 
start treatment 
14 Hospital 
10 Male 75-80 Higher 
Education 
Professional/
Management 
Retired Chronic 
lymphocytic 
leukaemia 
 
2-3years Watchful 
waiting 
Blood tests Indicate need to 
start treatment 
28 Hospital 
24 
 
11 Female 30-35 Higher 
education  
Professional/
Management 
Sickness 
absence 
Hodgkin’s 
lymphoma 
4months Mid-course of 
treatment 
PET scan Indicate need for 
increased treatment 
dose. 
 
14 Hospital 
12 Female 65-70 School Office/ 
Clerical 
Retired Non- 
Hodgkin’s 
lymphoma 
1week Newly 
diagnosed 
and under 
investigation 
 
CT and 
MRI scan 
Confirm diagnosis 
and disease location 
 
 
7 Hospital 
13 Female 50-55 Higher 
education 
Care Working Non- 
Hodgkin’s 
lymphoma 
7years Watchful 
waiting 
Stomach 
biopsy, 
ultrasound, 
blood tests2 
 
No intervention 
required 
14 Hospital 
14 Female 60-65 School Office/clerical Retired Chronic 
lymphocytic 
leukaemia 
2years Awaiting start 
of treatment 
 
CT scan 
and blood 
tests 
Start treatment 
imminently  
 
 
7 Hospital 
15 Male 25-30 Higher 
education 
Professional/
Management 
Sickness 
absence 
Hodgkin’s 
lymphoma 
2months Mid-course of 
treatment 
Blood tests Treatment 
effective: continue 
 
14 Hospital 
16 Male 25-30 School Manual Sickness 
absence 
Non- 
Hodgkin’s 
lymphoma  
 
2weeks Mid-course of 
treatment  
PET scan 
and blood 
tests 
More detailed 
diagnostic 
information with 
treatment 
implications  
 
7 Hospital 
17 Female 60-65 Higher 
education 
Office/clerical Retired Hodgkin’s 
lymphoma 
 
14months Mid-course of 
treatment 
PET scan 
and blood 
tests 
Treatment 
effective: continue 
 
21 Home 
18 Male 60-65 School Manual Unemployed 
 
Chronic 
lymphocytic 
leukaemia 
 
3years Watchful 
waiting 
Blood tests No treatment 
needed 
5 Hospital 
19 Male 60-65 School Office/ 
clerical  
Retired  Non- 
Hodgkin’s 
lymphoma 
 
3months Recently 
started 
treatment 
Blood tests Treatment 
effective: continue 
 
5 Hospital 
20 Male 40-45 Higher 
education  
Professional/
Management 
Working T-cell 
leukaemia 
6months Mid-course of 
treatment 
CT scan 
and blood 
tests 
Treatment 
effective: continue 
 
21 Hospital 
1In the index consultation patients’ results were given by 2a specialist trainee in haematology or 3senior pharmacist where shown above; all others were given by a 
consultant haematologist.  
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Appendix 2. Variant cases: three patients indicated that they wanted information that they 
had been unable to obtain.  
P13’s need arose from her own sense of medical knowledge and authority. 
Diagnosed with MALT Lymphoma 7 years previously, she had not yet needed treatment. 
Having “always had a fascination with human biology” and having done “all my nursing 
qualifications” she felt that “over the years that I’ve been coming as a patient I’ve always 
known what they [doctors] were talking about”. She thought her knowledge sometimes 
surpassed doctors’. For instance she described telling a surgeon immediately before 
previous gynaecological surgery “how to cut and where to cut”.  She routinely used 
clinical information to monitor her treatment and watch for “red lights”. She wanted to 
know why practitioners continued to ask for blood samples, given her understanding that 
blood samples at diagnosis had not detected her lymphoma. She had asked this “numerous 
times and never been given an answer…What are they looking for that didn’t show up 
[then]? That’s what is bamboozling me…And no-one gives me an answer.” 
Two others recounted a history of perceived failures in care that reduced their trust in 
practitioners. 
For P3, lack of continuity had left him feeling overlooked and with inconsistent 
information; he wanted a single practitioner to take responsibility.   
He described a year of undiagnosed poor health before his diagnosis, managed by his 
general practitioner (GP) culminating in emergency hospital admission during which he 
was diagnosed with lymphoma. He had lost trust in the GP (“You never see the same 
doctor twice hardly anyway”), a pattern repeated in hospital care: “One of the worst 
things about the [diagnostic] process, you get passed on from one person to another to 
another and nobody knows you, you’re just a file”. In the haematology clinic, he linked 
continuing discontinuity to not feeling cared for; for post-treatment results he saw a doctor 
new to him: “it was the first time she [doctor] had picked up my file…If it’d been bad, 
then it’d be somebody who I’d never seen before telling me...I didn’t like that”. 
Discontinuity also led to different kinds of stories…If [the same] person had said 
something back here you could say ‘Why has that changed?’ But if the one who’s saying 
it’s a different person then they probably don’t know”. For P3, the solution was that“at 
certain points you see the same person…at some point somebody comes in and 
says…‘I’ve had a look at it and everything’s OK but I’m passing you on to so and so 
who’ll deal with you for the next two but I’ll see you again on whenever’”.  
P11 similarly felt a lack of caring in the pre-diagnosis period. Now, she wants to see the 
PET scan results that would validate her practitioners’ report that her treatment was 
working. 
She felt “fobbed-off” during her journey to diagnosis of Hodgkin’s lymphoma, initially by 
a GP who attributed her symptoms benignly, then by hospital staff who could not perform 
a planned biopsy when she attended for it and then did not have results available for her 
outpatient appointment. Once she started haematology treatment she received printed 
information sheets but felt overlooked as an individual. Now she wanted to see images 
from her recent PET scan “for my own peace of mind” to confirm what her doctor had 
told her: “I know its [tumour] shrunk but…no-one has gone through that really although I 
have asked.”  She complained that: “I’ve asked to see [scan images]…they kept saying 
they would bring them but…But I have still not seen them.” 
 
